Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world

• Main Authors: Dana J Murdock (Author), Keran Moll (Author), Robert J Sanchez (Author), Jing Gu (Author), Sergio Fazio (Author), Gregory P Geba (Author), Fatima Rodriguez (Author)
• Format: Book
• Published: Elsevier, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Apolipoprotein B (ApoB) and lipoprotein (a) (Lp[a]) are predictors of cardiovascular disease (CVD) risk; therefore, current recommendations for CVD risk assessment and management advocate that patients receive testing for ApoB and Lp(a) in addition to the standard lipid panel. However, US...